Abstract
To evaluate the effects of saponins from Chinese Buckeye Seed in the treatment of cerebral edema in patients with stroke or cerebral trauma, a metaanalysis of randomized controlled trials was conducted. Randomized trials that compare the effects of treatment with saponins from Chinese Buckeye Seed to placebo treatment, to lack of treatment, to non-specific treatment, or to mannitol treatment for cerebral edema were identified with electronic and manual searches. No blinding and language limitations were applied. The methodological quality of trials was assessed with the Jadad scale plus allocation concealment. The metaanalysis was performed where data were available. Forty-one randomized controlled trials involving 4066 patients were identified. The methodological quality of the trials was generally low. The combined results showed that intravenous administration of saponins from Chinese Buckeye Seed increased the total effective rate, reduced the mortality and the incidence of renal function impairment in comparison to control treatment. No serious adverse event was reported. Based on the metaanalysis, saponins from Chinese Buckeye Seed can reduce cerebral edema in patients with stroke or cerebral trauma. However, the evidence is not sufficient due to the generally low methodological quality of the studies. Further trials are needed with sufficiently numerous group size and rigorous design.
Key words
Chinese Buckeye Seed -
Aesculus wilsonii
-
A. Chinensis
- Hippocastanaceae - cerebral edema - metaanalysis - randomized controlled trial
References
-
1
Bingaman W E, Frank J I.
Malignant cerebral edema and intracranial hypertension.
Neurol Clin.
1995;
13
479-509
-
2
Lang E W, Chesnut R M.
Intracranial pressure. Monitoring and management.
Neurosurg Clin N Am.
1994;
5
573-605
-
3
Georgiadis A L, Suarez J I.
Hypertonic saline for cerebral edema.
Curr Neurol Neurosci Rep.
2003;
3
524-30
-
4 The Pharmacopoeia Commission of P RC. Pharamacopoeia of the People’s Republic of China, (English edition 1997). Beijin; Chemical Industry Press 1997 Vol. I: p 207
-
5
Wei F, Ma L Y, Jin W T, Ma S C, Han G Z, Khan I A, Lin R C.
Anti-inflammatory triterpenoid saponins from the seeds of Aesculus chinensis
.
Chem Pharm Bull (Tokyo).
2004;
52
1246-8
-
6
Jadad A R, Moore R A, Carroll D, Jenkinson C, Reynolds D J, Gavaghan D J. et al .
Assessing the quality of reports of randomized clinical trials: is blinding necessary?.
Control Clin Trials.
1996;
17
1-12
-
7
Zheng C J.
Beta-escin for cerebral hemorrhage in 42 patients [in Chinese].
Henan J Pract Nerv Dis.
2003;
6
77-8
-
8
Zhang C Y, Wen Z M, Bao S Y.
Beta-escin for acute cerebral hemorrhage in 123 patients [in Chinese].
Suzhou Univ J Med Sci.
2003;
23
346-8
-
9
He Q L, Zhang Y, Dai Y N, Huang G Q, Zhang X X, Guo H S.
Beta-escin for acute cerebral infarction [in Chinese].
J Guangdong Med Coll.
2003;
21
157-9
-
10
Yang Z.
Beta-escin with mannitol for cerebral hemorrhage [in Chinese].
Henan J Pract Nerv Dis.
2003;
6
85
-
11
Song Y X.
Beta-escin with mannitol for cerebral hemorrhage in 40 patients [in Chinese].
J Diffic Compl Cas.
2002;
1
230-1
-
12
Pan G Q, Fang Q, Xu L Z.
Beta-escin for cerebral hemorrhage [in Chinese].
Chin J Hemorh.
2002;
12
313-4
-
13
Zhu T, Zheng Y.
Beta-escin with mannitol for cerebral hemorrhage [in Chinese].
Henan J Pract Nerv Dis.
2002;
5
53-4
-
14
Chen Z D, Shen H P.
Beta-escin with mannitol for cerebral hemorrhage [in Chinese].
Zhejiang Clin Med J.
2002;
4
668
-
15
Gao S S, Ma J W.
Beta-escin with mannitol for stroke [in Chinese].
Clin Med J China.
2002;
9
311-2
-
16
Qiu Y Z.
Beta-escin for cerebral infarction [in Chinese].
China J Mod Med.
2002;
12
73-5
-
17
Wen D S, Qiu R, Yao S J.
Beta-escin for cerebral infarction in early rehabilitation [in Chinese].
Clin Focus.
2002;
17
128-9
-
18
Tang J W.
Analysis of beta-escin for cerebral hemorrhage [in Chinese].
J Med Theor Prac.
2002;
15
30-1
-
19
Wang Y F, Lang Y M.
Beta-escin for cerebral trauma [in Chinese].
Chin JMAP.
2001;
18
496
-
20
Ni Z Q, Han J G, Jia X L.
Beta-escin for extensive cerebral trauma in 60 patients [in Chinese].
J Hunan Coll TCM.
2001;
21
51-2
-
21
Peng W Z, Zhang X C, Yang K Z, Qin Z H.
Beta-escin with defibrase for cerebral infarction in old patients [in Chinese].
Youjiang Med J.
2001;
29
186
-
22
Cheng G Z.
Beta-escin with mannitol for cerebral hemorrhage [in Chinese].
J Brain Nerv Dis.
2001;
9
179
-
23
Jin W.
Beta-escin for cerebral hemorrhage in 50 patients [in Chinese].
China Contemp Med.
2001;
7
76-7
-
24
Li F, Gu D X, Lv X J, Shi J M.
Effect of beta-aescin in natrum on cerebral blood flow in patients with cerebral hemorrhage induced by hypertension [in Chinese].
Chin J Integr Tradit West Med Intensive Crit Care.
2001;
8
116-7
-
25
Hua M J, Zhou H T, Zhang M D.
Discussion of beta-aescinum sodium for the treatment of acute cerebrovascular disease [in Chinese].
Mod Diagn Treat.
2000;
11
321-2
-
26
Yang G Q, Duan Z, Chen X L, Zhang X H.
Comparison of beta-aescine sodium, mannitol and DXM in treating traumatic encephaledema [in Chinese].
Chin J Med Writing.
2000;
7
1958-60
-
27
Chen J H.
Beta-escin with mannitol for cerebral edema in patients with cerebral trauma [in Chinese].
Nanjing Troops Med.
2000;
2
37-8
-
28
Meng Q F.
Beta-escin for cerebral hemorrhage in 68 patients [in Chinese].
Herald Med.
2000;
19
350
-
29
Liu P C, Wang P.
Beta-escin for cerebral edema in 50 patients [in Chinese].
Chin J Inf Tradit Chin Med.
1999;
6
62
-
30
Wang L, Huang D, Li C X.
Beta-escin with mannitol for cerebral hemorrhage in 28 patients [in Chinese].
Cent Plains Med J.
1999;
26
13-4
-
31
Hu Z C, Sheng X B, Lu A M.
ILIB with beta-escin for cerebral infarction in 37 patients [in Chinese].
Shandong Med J.
1999;
39
45
-
32
Li Z Y, Wang S Y, Gu T B.
Beta-escin for cerebral hemorrhage in 30 patients [in Chinese].
Henan J Pract Nerv Dis.
1999;
2
42
-
33
Zhang J S, Shi S P, Cui X C.
Beta-escin for cerebral infarction in the early period [in Chinese].
Chin Med Technol.
1999;
6
267
-
34
Chen L X, Zhang Y J.
Beta-escin for acute cerebral infarction in 65 patients [in Chinese].
Chin J Rural Med pharm.
1999;
6
9-10
-
35
Luo Y.
Observation of Beta-escin with mannitol for acute cerebral infarction in the near future [in Chinese].
Clin Focus.
1999;
14
612-3
-
36
Qu L X, Wang X Q, Su S H.
Beta-escin for cerebral hemorrhage [in Chinese].
J Pract Med Tech.
1999;
6
102
-
37
Zhang X P, Xie A M.
Observation of curative effect of beta-escin combined with mannitol on cerebrovascular disease [in Chinese].
J Taishan Med Coll.
1998;
19
209-12
-
38
Lian M Z, Hong Q X, Zhang S X.
Beta-escin with low molecular dextran for cerebral infarction [in Chinese].
Strait Pharm J.
1997;
9
89-90
-
39
Li F, Gu D X, Cao Z Z, Zhang R Q, Zhu R R.
Aescine in treatment of cerebral hemorrhage [in Chinese].
Chin J New Drugs Clin Remedies.
1998;
17
75-7
-
40
Gao H J, Geng W J, Liu J.
Beta-escin for developing cerebral infarction [in Chinese].
Pract J Rural Doct.
1998;
5
20
-
41
He S Q.
Beta-escin for stroke in 108 patients [in Chinese].
Mine Factory Med.
1997;
13
195-6
-
42
Wang A T, Jia H X, Hao X Z.
Beta-escin with mannitol for cerebral hemorrhage in 36 patients [in Chinese].
Pract J Card Cereb Pneumal Vasc Dis.
1997;
5
47-8
-
43
Gu D X, Li F, Zhang R Q, Lv X J, Shi J M.
Effect of beta-escin and composite Salvia milthiorrhiza on cerebral blood flow, blood haemorrheology and platelet function of patients with cerebral infarction [in Chinese].
Integr Tradit Chin West Med Pract Crit Care Med.
1997;
4
508-10
-
44
Zheng Q.
Beta-escin with mannitol for stroke in 131 patients [in Chinese].
Chin J Hosp Pharm.
1994;
14
352-3
-
45
Li Q F, Yang X J, Yang R L, Yang
X P.
Clinical observation of beta-escin and in treatment of intracerebral hemorrhage [in Chinese].
Med Forum J.
2003;
24
18-9
-
46
Xu S Z, Kong X M, Li J, Zhu J.
Beta-escin with mannitol for acute stroke in 120 patients [in Chinese].
Chin J Tradit West Med.
2003;
4
1518
-
47
Miao Z H, Wang G H.
Beta-escin for cerebral trauma [in Chinese].
Cent Plains Med J.
2004;
31
47-8
-
48
Dickersin K, Min Y I, Meinert C L.
Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards.
J Am Med Assoc.
1992;
267
374-8
-
49
Gorini S, Caponi R.
Evaluation of the pharmacological action of escin in experimental cerebral edema produced by craniotomy.
Minerva Neurochir.
1967;
11
357-9
-
50
Heppner F, Ascher W P, Argyropoulus G.
Current observations on the effect of aescin in neurosurgery.
Wien Med Wochenschr.
1967;
117
706-9
-
51
Put T R.
Advances in the conservative treatment of acute traumatic cerebral edema. Controlled clinical trial with follow-up examination.
Munch Med Wochenschr.
1979;
121
1019-22
-
52
Diemath H E.
Treatment and follow-up treatment in head injuries.
Wien Klin Wochenschr Suppl.
1981;
131
1-8
-
53
Hu X M, Zhang Y, Zeng F D.
Effects of sodium beta-aescin on expression of adhesion molecules and migration of neutrophils after middle cerebral artery occlusion in rats.
Acta Pharmacol Sin.
2004;
25
869-75
Prof. Xiaoting Wu
Department of Surgery
West China Hospital
Sichuan University
37 Guo Xue Rd.
Chengdu 610041
Sichuan Province
People’s Republic of China
Phone: +86-28-8542-3411
Fax: 86-28-8542-2411
Email: nutritioner@hotmail.com
